BMJ Open (Apr 2022)
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
- Mieke Van Hemelrijck,
- Muhammad Imran Omar,
- Jihong Zong,
- Katharina Beyer,
- Lisa Moris,
- Michael Lardas,
- Anna Haire,
- Francesco Barletta,
- Simone Scuderi,
- Eleni Vradi,
- Giorgio Gandaglia,
- Steven MacLennan,
- Bahman Farahmand,
- Sara J Maclennan,
- Zsuzsanna Devecseri,
- Alex Asiimwe,
- Laurence Collette,
- Anders Bjartell,
- James Ndow,
- Alberto Briganti,
- Thomas Van den Broeck,
- Riccardo Campi,
- Isabella Greco,
- Mauro Gacci,
- Megan Molnar,
- Ronald Herrera,
- Monique J Roobol,
- Abdul Rauf,
- Kirill Shiranov,
- Saeed Dabestani,
- Sujenthiran Arun
Affiliations
- Mieke Van Hemelrijck
- Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK
- Muhammad Imran Omar
- Academic Urology Unit/Cochrane Incontinence Group, University of Aberdeen, Aberdeen, UK
- Jihong Zong
- 3 Epidemiology, Bayer U.S. Whippany, New Jersey, USA
- Katharina Beyer
- King`s College London – Strand Campus, London, London, UK
- Lisa Moris
- Department of Urology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium
- Michael Lardas
- Department of Urology, Metropolitan Hospital Athens, Athens, Attike, Greece
- Anna Haire
- School of Cancer and Pharmaceutical Sciences, King`s College London, London, UK
- Francesco Barletta
- Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy
- Simone Scuderi
- Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy
- Eleni Vradi
- Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany
- Giorgio Gandaglia
- Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy
- Steven MacLennan
- Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK
- Bahman Farahmand
- Global Epidemiology, Bayer AG, Stockholm, Sweden
- Sara J Maclennan
- Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK
- Zsuzsanna Devecseri
- Sanofi SA, Paris, Île-de-France, France
- Alex Asiimwe
- Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany
- Laurence Collette
- EORTC, Brussels, Belgium
- Anders Bjartell
- Skåne University Hospital, Malmö, Sweden
- James Ndow
- Guidelines Office, European Association of Urology, Arnhem, Netherlands
- Alberto Briganti
- Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IBCAS San Raffaele Scientific Institute, Milan, Lombardia, Italy
- Thomas Van den Broeck
- Department of Urology, University Hospitals Leuven, Leuven, Belgium
- Riccardo Campi
- Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy
- Isabella Greco
- Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy
- Mauro Gacci
- Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy
- Megan Molnar
- Bayer AG, Berlin, Germany
- Ronald Herrera
- 1 Occupational and Environmental Epidemiology and NetTeaching Unit, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital Munich (LMU), Munich, Germany
- Monique J Roobol
- Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
- Abdul Rauf
- Department of Pediatrics, Baby Memorial Hospital, Calicut, Kerala, India
- Kirill Shiranov
- CDC Zdorovie, Rostov-on-Don, Russia
- Saeed Dabestani
- Dept. of Translational Medicine, Division of Urological Cancers, Lund University, Kristianstad Central Hospital, Malmo, Sweden
- Sujenthiran Arun
- Flatiron Health, London, UK
- DOI
- https://doi.org/10.1136/bmjopen-2021-058267
- Journal volume & issue
-
Vol. 12,
no. 4
Abstract
No abstracts available.